

Botox treatment for hand sweating involves injecting small doses of botulinum toxin into areas of the palms affected by excessive sweating. Botulinum toxin temporarily reduces the nerve signals reaching the sweat glands and suppresses sweat production in the treated area.
Excessive sweating of the palms is known as palmar hyperhidrosis. In some people, the hands remain constantly moist, while in others sweat may drip from the palms. Writing, using a phone, holding documents, shaking hands, driving, and working with delicate instruments may become difficult.
Botox for hand sweating is a non-surgical, temporary local treatment. The sweat glands are not permanently destroyed, and the sympathetic nerves are not cut. As the effect of the medication decreases, communication between the nerves and sweat glands gradually returns, and sweating may recur.
Because the palms contain many nerve endings, injections may be more painful than underarm Botox. Pain-control methods should therefore be planned before the procedure. Temporary weakness of grip or finger movement may also occur if botulinum toxin reaches the nearby small hand muscles.
When deciding on treatment, the severity of sweating, previous treatments, the patient’s occupation, need for manual dexterity, expectations, and possible side effects are evaluated together.
Hand sweating is excessive activity of the sweat glands in the palms. Sweating of the hands during hot weather, exercise, stress, or excitement may be natural. However, palmar hyperhidrosis may be present when the hands remain wet even when the body does not need to cool down.
Primary palmar hyperhidrosis usually:
Some people experience only palm sweating. In others, sweating of the feet, underarms, or face may accompany hand sweating.
Hand sweating is not simply a skin problem that causes wet palms. When severe, it may affect social, professional, and educational life.
People with palmar hyperhidrosis may:
Anxiety caused by noticing the sweating may further stimulate the sympathetic nervous system and increase sweating. This may create a cycle in which stress and sweating reinforce one another.
The sweat glands in the palms are controlled by the autonomic nervous system. A chemical substance called acetylcholine is released from nerve endings and signals the sweat glands to become active.
In primary palmar hyperhidrosis, the number of sweat glands is usually normal. The main problem is excessive nerve stimulation reaching these glands.
Botulinum toxin temporarily reduces the release of acetylcholine from nerve endings in the treated area. As a result, the signal reaching the sweat glands becomes weaker and sweat production in the palms decreases.
Botulinum toxin:
Botox for hand sweating is therefore not a permanent treatment. However, while effective, it may reduce excessive palm sweating enough to improve daily life.
The word Botox is commonly used as a general term for botulinum toxin procedures. However, Botox is the brand name of a particular botulinum toxin product.
Different types and commercial products of botulinum toxin are available. Their:
are not completely identical.
A dose used for one botulinum toxin product cannot be directly converted into the dose of another product. The product, total dose, dilution, and injection plan should be determined by the doctor.
The regulatory approval status of botulinum toxin for hyperhidrosis varies according to the product and country.
For example, the United States approval for onabotulinumtoxinA in hyperhidrosis covers severe primary underarm sweating that cannot be adequately controlled with topical treatments. Its use for palm sweating may be off-label.
Off-label use means that a medication is used by a doctor outside its officially approved indication, based on scientific evidence and clinical assessment. It does not automatically mean that the treatment is ineffective or prohibited.
Although clinical studies have evaluated botulinum toxin for hand sweating, patients should be informed about:
Botulinum toxin may be considered in selected patients whose hand sweating significantly affects daily life and who have not obtained sufficient benefit from appropriate non-surgical treatments.
Treatment may be considered when:
Suitability is not determined only by the amount of sweat. The effect on the person’s quality of life is also considered.
Botulinum toxin is not usually the first treatment used for hand sweating.
Primary palmar hyperhidrosis is generally treated gradually, beginning with less invasive methods.
Treatment options may include:
The order of treatment may vary according to sweating severity, skin characteristics, previous treatments, general health, and patient expectations.
Botox may be considered particularly when topical treatments and iontophoresis are insufficient but the patient does not want surgery.
No. Hand sweating is not always caused by primary hyperhidrosis.
The underlying condition should be evaluated first when sweating is caused by:
Botox does not treat the disease causing secondary sweating. For example, when sudden sweating is caused by low blood sugar, the priority is to assess and treat the glucose problem.
Before treatment, the patient’s medical history is reviewed and the hands are examined.
The following questions may be considered:
When the typical features of primary palmar hyperhidrosis are present, diagnosis can usually be made through medical history and examination.
Extensive routine blood tests may not be necessary in otherwise healthy people with typical primary palmar hyperhidrosis solely because Botox is planned.
However, testing for secondary causes may be considered when hand sweating:
Depending on the symptoms, tests may include:
Not every patient needs all of these tests. Testing is selected according to the symptoms.
Temporary muscle weakness is one of the important local side effects of hand Botox. The person’s hand function and professional requirements should therefore be assessed before treatment.
Detailed evaluation is particularly important for:
When necessary, grip strength and finger movement may be documented clinically before treatment. This allows any changes after the procedure to be assessed more accurately.
The sweating area in the palms may be identified through the patient’s description and physical examination.
If the distribution is unclear, an iodine-starch test may be used.
During the test:
The colour change shows the areas of active sweating and may help plan the injections.
The test does not identify the cause of sweating. It only maps the areas where sweat glands are most active.
In some people, sweating affects not only the palms but also the inner surfaces and tips of the fingers.
The treatment area is selected according to the distribution of sweating. If the fingers are affected, they may be included in the injection plan.
However, in the fingers:
Hand Botox should therefore be planned according to the individual’s sweating pattern and hand anatomy rather than a standard template.
The palms and fingers contain many nerve endings responsible for touch and pain sensation.
Botulinum toxin is not injected into a single point. Multiple small injections are used to cover the entire sweating area. Even though each injection is superficial, the overall procedure may be uncomfortable.
The level of pain varies according to:
Beginning the procedure without adequate pain control may make it difficult for the patient to complete the treatment.
Different pain-control methods may be used during hand Botox.
A topical anaesthetic cream may be applied to the palms before the procedure.
However, because the skin of the palms is thick, the cream may not provide sufficient numbness in every patient. Injection pain may continue in the centre of the palm and fingertips.
Cold may be applied before and during the injections.
Cooling may temporarily reduce pain sensation. However, it may not make extensive palm injections completely painless when used alone.
Vibration applied near the injection area may reduce the perception of pain signals.
This method may be combined with other local pain-control techniques.
A local anaesthetic may be injected around nerves such as the median and ulnar nerves to temporarily numb a large portion of the hand.
A nerve block may make palm injections more comfortable. However, it:
The nerve block should be performed by a physician experienced in the procedure.
In some patients, local anaesthetic may be injected into the treatment area.
The pain-control method is selected according to the patient’s health, treatment area, pain sensitivity, and the medical centre’s protocol.
After a regional nerve block, temporary numbness, reduced sensation, and difficulty moving the hand or fingers may occur.
Until sensation returns completely:
Because the person cannot fully feel the hand, accidental burns, cuts, or crushing injuries may occur.
The doctor should be informed if numbness lasts longer than expected or severe pain develops.
Although the procedure may vary according to the medical centre and the patient’s needs, it generally involves the following steps:
The injections are intended to remain as superficial as possible within the skin. Deeper injection or spread into the muscles may increase the risk of temporary weakness.
The total dose and number of injections may vary according to:
Dosage units of different botulinum toxin products cannot be directly substituted for one another.
Both hands may be treated during the same session in suitable patients.
However, when both hands are treated:
For people whose work or daily life depends heavily on hand use, the doctor and patient may decide whether both hands should be treated together or at separate times.
The duration depends on the size of the treatment area, number of injections, and anaesthesia method.
The injection stage itself may be relatively short. However:
may increase the total time.
Hand Botox generally does not require hospital admission. The patient can usually return home on the same day.
The effect of botulinum toxin does not begin fully at the time of injection.
A reduction in sweating:
Continued sweating during the first few days does not mean that treatment has failed.
If sweating remains in certain areas after two weeks, parts of the palm may not have been fully covered by the injections. The doctor decides whether additional treatment is necessary.
The effect of botulinum toxin is not permanent.
The reduction in palm sweating usually continues for several months. In some people the effect may be shorter, while in others it may last longer.
Duration may be influenced by:
Sweating usually returns gradually as the effect wears off. The hands do not necessarily return suddenly to their previous level of sweating.
There is no fixed repeat schedule that applies to everyone.
Repeat treatment may be planned when:
Treatment is not repeated unnecessarily early while the previous effect is still active.
The effectiveness and duration of the previous procedure and whether it caused muscle weakness are considered when planning the next treatment.
Many patients continue to achieve sweating control with repeated treatments.
If the effect appears to decrease over time, the following may be assessed:
When the effect decreases, the cause should be investigated rather than automatically increasing the dose.
Botulinum toxin may significantly reduce sweating of the palms.
In some people, the hands become almost completely dry. In others, sweating does not stop entirely but decreases enough not to interfere with daily life.
Treatment success may be assessed through improvements such as:
The goal is not to eliminate natural sweating completely but to reduce excessive and uncontrollable sweating.
Some people may experience more dryness than expected after treatment.
Excessive dryness may cause:
Using a suitable moisturiser may help protect the skin barrier.
Dermatological evaluation may be needed if severe dryness, cracking, or wounds develop.
Temporary weakness of grip or finger movement may occur if botulinum toxin spreads to nearby small muscles.
The person may have difficulty with:
The severity varies from person to person. In some individuals it is mild and barely noticeable, while in others it may affect professional activities.
This effect is generally temporary. Muscle function may improve as the botulinum toxin effect decreases.
The duration of temporary muscle weakness depends on:
Weakness may decrease within several weeks. However, the exact duration is not the same for everyone.
The treating doctor should be contacted if weakness significantly affects daily tasks, becomes worse, or lasts longer than expected.
Botulinum toxin does not primarily numb sensory nerves. Permanent loss of sensation is therefore not an expected effect.
However:
may cause temporary numbness or tingling.
Medical evaluation is required if numbness continues longer than the expected duration of anaesthesia or is accompanied by severe pain or loss of muscle function.
Possible side effects include:
These effects are usually temporary.
Increasing redness, warmth, swelling, discharge, or severe pain at the injection site should be evaluated for possible infection.
Botulinum toxin product information includes serious warnings about the possible spread of toxin effects beyond the injection area.
Although serious systemic spread is very rare when appropriate doses are used for hyperhidrosis, urgent medical assessment is required if any of the following develop:
These symptoms may appear hours or days after treatment.
The procedure should be performed in a medical setting using approved products by a physician experienced in botulinum toxin treatment.
Hand Botox does not cut the sympathetic nerve pathways in the way endoscopic thoracic sympathetic surgery does.
Classic compensatory sweating seen after surgery is therefore not an expected major side effect of hand Botox.
After hand sweating decreases, the person may become more aware of existing sweating in the feet, underarms, or other areas. This does not necessarily mean that sweating has actually increased.
Normal sweating continues in untreated areas.
The sweat glands in the palms represent only a small part of the glands involved in regulating body temperature.
Treating only the hands generally does not eliminate the body’s overall ability to regulate heat. Sweat glands in other areas continue to function.
However, treatment planning should be assessed separately when botulinum toxin is applied to several large body areas at the same time or when the patient performs heavy physical activity in hot environments.
Botulinum toxin may not be used in the following situations:
Some conditions may not be absolute contraindications but require detailed assessment.
The doctor should be informed about:
All medications, vitamins, and supplements should be reported to the doctor.
Blood-thinning medication should not be stopped without medical advice solely to reduce bruising.
Safety data regarding botulinum toxin for hyperhidrosis during pregnancy and breastfeeding are limited.
Because hand sweating is generally not an emergency condition, treatment may be postponed until after pregnancy.
During breastfeeding, the decision should consider:
Anyone who may be pregnant or is breastfeeding should inform the doctor before treatment.
Primary palmar hyperhidrosis may begin during childhood or adolescence and significantly affect school life.
However, approval status and age limits for botulinum toxin in hand sweating vary according to the product and country.
In children and adolescents, the following should be assessed first:
The treatment decision should be made by physicians experienced in paediatric hyperhidrosis and botulinum toxin.
The treating doctor’s instructions should be followed after the procedure.
General recommendations may include:
Post-treatment instructions may vary according to the anaesthesia method and the patient’s occupation.
H2: Can the Hands Be Washed After Botox?
The treating doctor’s recommendations should be followed.
Gentle hand washing with lukewarm water is generally unlikely to cause a problem. However, immediately after treatment it may be advisable to avoid:
Instructions regarding cleaning and skincare should be followed if the injection sites remain open or tender.
If a nerve block or local anaesthesia has been used, numbness, reduced sensation, or temporary movement difficulty may occur.
Driving should be avoided until numbness has completely resolved and hand function has returned to normal.
Even without anaesthesia, driving may be affected if pain, tenderness, or weakness is present.
Return to driving depends on hand function and the anaesthesia method used.
Most people can return to routine daily life on the same day. However, return to work depends on the nature of the job.
A person with a desk job may return quickly, while those who:
may need more careful planning.
Numbness caused by a nerve block or temporary weakness caused by botulinum toxin may affect professional performance.
Heavy hand exercises, weightlifting, or sports requiring strong grip may be restricted on the day of treatment.
If a nerve block has been performed, exercise should be avoided until sensation has fully returned.
Return to normal activity depends on:
Because the full effect of botulinum toxin does not appear immediately, follow-up assessment may be recommended.
During follow-up, the doctor may evaluate:
The full response is usually assessed after the medication has had time to take effect rather than on the first day.
If sweating does not decrease sufficiently after Botox, the cause should be assessed.
Possible reasons include:
If sweating continues in isolated areas, the doctor may consider additional injections.
If the treatment is completely ineffective, iontophoresis, oral medications, or surgical options in suitable patients may be reconsidered.
Iontophoresis involves placing the hands in trays of water and passing a low electrical current through the skin.
Iontophoresis:
Hand Botox:
Iontophoresis is commonly considered before hand Botox. However, treatment selection depends on the patient’s previous experience, available time, and preferences.
Certain oral anticholinergic medications may affect sweat glands in several parts of the body.
These medications:
Hand Botox targets only the injected area. Whole-body anticholinergic side effects such as dry mouth are therefore not expected.
However, injection pain and temporary weakness of the hand muscles may occur.
Endoscopic thoracic sympathetic surgery may be considered for severe primary hand sweating.
Hand Botox:
Endoscopic thoracic sympathetic surgery:
Surgery is not selected only because Botox is temporary. Sweating severity, previous treatments, patient expectations, and acceptance of compensatory sweating risk are considered.
Patients who obtain sufficient benefit from botulinum toxin and accept repeat treatment may not need surgery.
Some patients may:
Other methods and surgical options may then be considered.
A good response to Botox does not mean that surgery will provide the same result or risk profile. Botox and sympathetic surgery work through different mechanisms.
Botulinum toxin may help show how reducing hand sweating affects the person’s quality of life.
However, Botox:
A good response to Botox therefore does not guarantee that surgery will be successful.
The severity of sweating, response to other treatments, and risk of compensatory sweating must still be assessed separately.
With appropriate patient selection, correct injection technique, suitable dosing, and approved products, botulinum toxin may be an effective treatment for hand sweating.
Safety is influenced by:
Hand Botox should not be regarded as a simple cosmetic procedure. It involves injecting a prescription medication close to nerves, muscles, and blood vessels.
Hand Botox should be performed by physicians experienced in diagnosing hyperhidrosis and administering botulinum toxin.
Initial assessment may be performed by dermatology, internal medicine, or family medicine.
Botulinum toxin treatment is commonly performed by dermatologists. Experience in hand anatomy, pain control, and temporary muscle weakness is important.
Patients considering surgery for primary palmar hyperhidrosis are evaluated by a thoracic surgeon.
The procedure should not be performed in non-medical settings where unapproved or unknown products may be used.
Mild pain, tenderness, bruising, and temporary weakness may occur after treatment.
The treating doctor should be contacted if there is:
Urgent medical assessment is required if difficulty swallowing, speaking, or breathing, double vision, or generalised muscle weakness develops.
Botox treatment for hand sweating involves injecting botulinum toxin into active sweating areas of the palms through multiple small injections.
Botulinum toxin temporarily reduces the acetylcholine signal reaching the sweat glands. The glands are not permanently destroyed, and the effect decreases over time.
Because the palms contain many nerve endings, treatment may be more painful than underarm Botox. Pain may be controlled with topical anaesthetic cream, cooling, or regional nerve blocks.
Sweating may begin to decrease within the first few days and become more noticeable within one or two weeks. The effect generally lasts for several months, and treatment may be repeated when sweating returns.
One of the important side effects is temporary weakness of grip or finger movement caused by spread of the medication to nearby small muscles. This risk should be evaluated particularly carefully in people whose occupation depends on precise manual skills.
Botulinum toxin is not suitable for every patient with hand sweating. Secondary causes should first be investigated when sweating begins suddenly, continues at night, affects only one side, or occurs throughout the body.
Treatment should be planned individually according to sweating severity, previous treatments, occupation, hand function, pain tolerance, and patient expectations.
After the sweating area is identified, the palms are cleaned and an appropriate pain-control method is used. Botulinum toxin is injected into the skin in small doses using fine needles to cover the entire sweating area.
The palms contain many nerve endings, so injections may be painful. Topical anaesthetic cream, cooling, or a regional nerve block may be used to reduce discomfort.
A reduction in sweating may be noticed within the first few days. A clearer effect generally appears within approximately one week. Full response may take one or two weeks to assess.
The effect varies between individuals but generally continues for several months. Sweating may gradually return as the effect wears off.
Temporary weakness of grip or finger movement may occur if botulinum toxin spreads to nearby small muscles. This risk is particularly important for people whose work depends on precise hand function.
If no anaesthesia has been used and there is no significant pain, light daily activities may be possible. If a nerve block was performed, the hand should be protected from hot, sharp, and heavy objects until numbness resolves completely.
Both hands may be treated in the same session in suitable patients. However, numbness, tenderness, or temporary weakness in both hands may make daily tasks difficult, so planning should consider the patient’s occupation.
Botulinum toxin does not cut the sympathetic nerve pathways, so classic compensatory sweating seen after surgery is not an expected major side effect. Normal sweating continues in untreated areas.
Iontophoresis does not require injections but needs initial and maintenance sessions. Botox may provide several months of benefit after one procedure but carries risks of pain and temporary hand weakness. The most suitable method depends on the patient’s treatment history and needs.
The procedure should be performed by a physician experienced in hyperhidrosis and botulinum toxin. Hand Botox is commonly performed by dermatologists. Patients considering surgery are evaluated by a thoracic surgeon.